Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 15, 2007
0Patent Application Number
104434660
Date Filed
May 22, 2003
0Patent Primary Examiner
Patent abstract
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
